M&A Deal Summary

Teva Pharmaceutical Industries Acquires Anda

On August 2, 2016, Teva Pharmaceutical Industries acquired distribution company Anda from Allergan for 500M USD

Acquisition Highlights
  • This is Teva Pharmaceutical Industries’ 1st transaction in the Distribution sector.
  • This is Teva Pharmaceutical Industries’ 9th largest (disclosed) transaction.
  • This is Teva Pharmaceutical Industries’ 15th transaction in the United States.
  • This is Teva Pharmaceutical Industries’ 3rd transaction in New Jersey.

M&A Deal Summary
Date 2016-08-02
Target Anda
Sector Distribution
Buyer(s) Teva Pharmaceutical Industries
Sellers(s) Allergan
Deal Type Divestiture
Deal Value 500M USD

Target

Anda

Parsippany, New Jersey, United States
Anda, Inc. is a distributor of generic pharmaceuticals.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Teva Pharmaceutical Industries

Tel Aviv, Israel
Category Company
Founded 1901
Sector Life Science
Employees35,001
Revenue 15.8B USD (2023)
DESCRIPTION

Teva Pharmaceutical Industries is a provider of pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Teva Pharmaceutical Industries was founded in 1901 and is based in Tel Aviv, Israel.

DEAL STATS #
Overall 23 of 23
Sector (Distribution) 1 of 1
Type (Divestiture) 4 of 4
State (New Jersey) 3 of 3
Country (United States) 15 of 15
Year (2016) 1 of 1
Size (of disclosed) 9 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-06-21 Teva Pharmaceutical Industries - Generic Products

Petach Tikva, Israel

Teva Pharmaceutical Industries Ltd. - Generic Products includes solid oral, inhalable, injectable and topical dosage forms and the return to Impax of its rights to its pending abbreviated new drug application ("ANDA") for the generic equivalent to Concerta.

Sell $586M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-09-11 Teva Pharmaceutical Industries - PARAGARD

Buffalo, New York, United States

PARAGARD is a copper-releasing device that is placed in the uterus to prevent pregnancy for up to 10 years.

Sell $1.1B

Seller(S) 1

SELLER

Allergan

Parsippany, New Jersey, United States
Category Company
Founded 1956
Sector Life Science
Employees31,200
Revenue 15.8B USD (2018)
DESCRIPTION

Allergan is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company was originally established in 1956 and is based in Parsippany, New Jersey.

DEAL STATS #
Overall 5 of 9
Sector (Distribution) 2 of 2
Type (Divestiture) 5 of 9
State (New Jersey) 2 of 4
Country (United States) 5 of 8
Year (2016) 1 of 3
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-04-21 Topokine Therapeutics

Boston, Massachusetts, United States

Topokine Therapeutics, Inc. is a clinical-stage biotechnology company developing topical prescription medications to contour the face and body non-invasively.

Buy $85M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-08-11 ForSight VISION5

Menlo Park, California, United States

ForSight VISION5, Inc. is a developer of non-invasive drug delivery products that replace eye drops and provide sustained therapy for major eye diseases including glaucoma, dry eye, and allergy.

Buy $95M
Mergr

Product

Company

Legal